Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
MEDXvsVHTETF Comparison
Horizon Kinetics Medical ETF (MEDX) belongs to the Tomorrow's Treatments segment. Vanguard Health Care ETF (VHT) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Health Care. MEDX is more expensive with a Total Expense Ratio (TER) of 0.85%, versus 0.09% for VHT. MEDX is up 2.53% year-to-date (YTD) with - in YTD flows. VHT performs worse with -1.5% YTD performance, and -$151M in YTD flows. Run a side-by-side ETF comparison of MEDX and VHT below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
MEDX vs VHT performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | MEDX VHT | -0.52%-1.42% | +4.39%+0.11% | +2.53%-1.50% | +20.47%+7.50% | +31.16%+30.03% | n/a+36.00% |
| Flows | MEDX VHT | --$76M | --$238M | --$151M | -$787K-$712M | -$2M-$2.54B | --$233M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | MEDX VHT | +18.47%+13.17% | +20.51%+17.33% | +16.50%+13.63% | n/a+14.97% |
| Max drawdown | MEDX VHT | -4.54%-5.00% | -15.78%-11.85% | -23.05%-16.88% | n/a-17.77% |
| Max drawdown duration | MEDX VHT | 9d62d | 163d190d | 393d435d | n/a767d |
MEDX | VHT | |
Last sale 3/11/2026 at 1:30 PM | $33.89 | $282.75 |
| Previous close 03/10/2026 | $34.07 | $283.48 |
| Consolidated volume 03/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
MEDX | VHT | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
MEDX | VHT | |
|---|---|---|
| Last price | $33.89 | $282.75 |
| 1D performance | -0.54% | -0.26% |
| AuM | $19.42 M | $16.92 B |
| E/R | 0.85% | 0.09% |
MEDX | VHT | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Horizon Kinetics LLC | Vanguard |
| Benchmark | - | MSCI US IMI Health Care 25/50 Index |
| N° of holdings | 24 | 352 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | January 27, 2023 | January 26, 2004 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the MEDX and VHT ETFs performed in 2026?
As of March 10, 2026, MEDX is up 2.53% year-to-date (YTD), while VHT has lost -1.5%. That puts MEDX better performer ahead so far this year.
Which ETF is attracting more investor money: MEDX or VHT?
Year-to-date, the MEDX ETF saw - in flows, compared to -$151M for VHT.
Which ETF is more volatile: MEDX or VHT?
Over the past year, MEDX had a volatility of 20.51%, while VHT experienced 17.33%.
Which ETF is bigger: MEDX or VHT?
As of March 10, 2026, MEDX holds $19.42 M in assets under management (AUM), while VHT manages $16.92 B.
What sectors do the MEDX and VHT ETFs invest in?
MEDX leans toward sectors like Health Care. Meanwhile, VHT focuses on Health Care.
What are the top holdings of the MEDX ETF and VHT ETF?
MEDX top holdings include LILLY, ABBVIE and US66987V1098. VHT holds in its top three: LILLY, JOHNSON&JOHNSON and ABBVIE.
Which ETF is more diversified: MEDX or VHT?
MEDX holds 29 securities with 81.25% of its assets in the top 15. VHT has 408 securities and a top 15 weight of 60.02%.
My Contrarian Equity ETF Picks For 2026
Healthcare Stocks Drop on Medicare Payment Rate Surprise
Health Care Sector Down After a Cyberattack on UnitedHealth
2024 Stock Market Predictions from Vanguard, BlackRock, & State Street: ETFs to Watch
Tony's ETF Buyer's Guide: Sector ETFs (Vanguard versus State Street SPDR)
Defensive investing: Utility and healthcare sector ETFs
Calamos Investments Powers the Next Phase of the Autocallable Revolution
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
